NO20080816L - Anvendelse av delmopinol ved behandling av kviser - Google Patents

Anvendelse av delmopinol ved behandling av kviser

Info

Publication number
NO20080816L
NO20080816L NO20080816A NO20080816A NO20080816L NO 20080816 L NO20080816 L NO 20080816L NO 20080816 A NO20080816 A NO 20080816A NO 20080816 A NO20080816 A NO 20080816A NO 20080816 L NO20080816 L NO 20080816L
Authority
NO
Norway
Prior art keywords
acne
treatment
carbon atoms
delmopinol
branched alkyl
Prior art date
Application number
NO20080816A
Other languages
English (en)
Inventor
Jonathan Douglas Lane
Original Assignee
Sinclair Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinclair Pharmaceuticals Ltd filed Critical Sinclair Pharmaceuticals Ltd
Publication of NO20080816L publication Critical patent/NO20080816L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Den foreliggende oppfinnelsen vedrører anvendelsen av en morfolinforbindelse med den generelle formelen: der R1 er en rettkjedet eller forgrenet alkylgruppe som inneholder 8 til 16 karbonatomer i 2- eller 3-posisjonen på morfolinringen, og R2 er en rettkjedet eller forgrenet alkylgruppe som inneholder 2 til 10 karbonatomer, substituert med en hydroksygruppe bortsett fra i alfa-posisjon, eller farmasøytisk akseptable salter derav, ved fremstilling av en sammensetning for behandling av kviser.
NO20080816A 2005-07-22 2008-02-14 Anvendelse av delmopinol ved behandling av kviser NO20080816L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0515138.6A GB0515138D0 (en) 2005-07-22 2005-07-22 Acne treatment
PCT/GB2006/002770 WO2007010294A2 (en) 2005-07-22 2006-07-24 Use of delmopinol in the treatment of acne

Publications (1)

Publication Number Publication Date
NO20080816L true NO20080816L (no) 2008-02-14

Family

ID=34976444

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080816A NO20080816L (no) 2005-07-22 2008-02-14 Anvendelse av delmopinol ved behandling av kviser

Country Status (17)

Country Link
US (1) US20080269222A1 (no)
EP (1) EP1933840B1 (no)
JP (1) JP2009502769A (no)
KR (2) KR20130126746A (no)
CN (1) CN101227910A (no)
AU (1) AU2006271396A1 (no)
BR (1) BRPI0613749A2 (no)
CA (1) CA2614846C (no)
DK (1) DK1933840T3 (no)
ES (1) ES2439453T3 (no)
GB (1) GB0515138D0 (no)
MX (1) MX2008000716A (no)
NO (1) NO20080816L (no)
PL (1) PL1933840T3 (no)
PT (1) PT1933840E (no)
RU (1) RU2008100220A (no)
WO (1) WO2007010294A2 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0502046D0 (en) 2005-02-01 2005-03-09 Sinclair Pharmaceuticals Ltd Method
GB0708960D0 (en) * 2007-05-09 2007-06-20 Sinclair Pharmaceuticals Ltd Method
GB0714338D0 (en) * 2007-07-23 2007-09-05 Sinclair Pharmaceuticals Ltd method
BR112018014184A2 (pt) 2016-01-11 2018-12-11 Klox Tech Limited composições biofotônicas para o tratamento de pioderma
IT201600130538A1 (it) 2016-12-23 2018-06-23 Lundbeck Pharmaceuticals Italy S P A Processo per la produzione del delmopinolo
IT201600130642A1 (it) 2016-12-23 2018-06-23 Lundbeck Pharmaceuticals Italy S P A Processo per la produzione di 2(3 alchilmorfolino)-etan-1-olo
IT201600130729A1 (it) 2016-12-23 2018-06-23 Lundbeck Pharmaceuticals Italy S P A Processo per la produzione degli intermedi del delmopinolo
IT201700076821A1 (it) * 2017-08-24 2019-02-24 Lundbeck Pharmaceuticals Italy S P A Nuovo sale del delmopinolo

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894221A (en) * 1981-03-19 1990-01-16 Ab Ferrosan Method of treating plaque using morpholine compounds
US5082653A (en) * 1990-10-31 1992-01-21 Warner-Lambert Company Anti-plaque compositions comprising a combination of morpholinoamino alcohol and antibiotic
ES2073776T3 (es) * 1990-11-09 1995-08-16 Pharmacia Ab Composiciones anti-placa mejoradas que comprenden una combinacion de morfolinoamino-alcohol y agente antimicrobiano.
US20050106111A1 (en) * 2003-09-16 2005-05-19 Aphios Corporation Compositions and methods for reducing dental plaque

Also Published As

Publication number Publication date
EP1933840A2 (en) 2008-06-25
CN101227910A (zh) 2008-07-23
US20080269222A1 (en) 2008-10-30
WO2007010294A3 (en) 2007-03-29
AU2006271396A1 (en) 2007-01-25
PT1933840E (pt) 2013-12-10
EP1933840B1 (en) 2013-11-13
WO2007010294A8 (en) 2008-02-21
RU2008100220A (ru) 2009-08-27
MX2008000716A (es) 2008-03-18
JP2009502769A (ja) 2009-01-29
DK1933840T3 (da) 2013-12-02
ES2439453T3 (es) 2014-01-23
BRPI0613749A2 (pt) 2011-02-08
KR20130126746A (ko) 2013-11-20
GB0515138D0 (en) 2005-08-31
PL1933840T3 (pl) 2014-03-31
CA2614846C (en) 2013-12-31
KR20080038332A (ko) 2008-05-06
WO2007010294A2 (en) 2007-01-25
CA2614846A1 (en) 2007-01-25

Similar Documents

Publication Publication Date Title
NO20080816L (no) Anvendelse av delmopinol ved behandling av kviser
NO20075641L (no) Kroman og kromenderivater og ders anvendelse
WO2007125321A3 (en) Purine and deazapurine derivatives as pharmaceutical compounds
MX2007005694A (es) Nuevos derivados de betulina, preparacion y uso de los mismos.
NO20085169L (no) Krystallinske solvater og komplekser av (1S)-1,5-anhydro-L-C- (3-((fenyl)metyl)fenyl)-D-glucitol derivater med aminosyrer som SGLT2-inhibitorer for behandling av diabetes
NO20085385L (no) Tiazolforbindelser som cannabinoidreseptorligander og anvendelser derav
EA200970461A1 (ru) ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ 3-ИЗОБУТИЛ-9,10-ДИМЕТОКСИ-1,3,4,6,7,11b-ГЕКСАГИДРО-2Н-ПИРИДО[2,1-a]ИЗОХИНОЛИН-2-ОЛА И СВЯЗАННЫЕ С НИМИ СПОСОБЫ
RS54260B1 (en) AMINODIHYDROTIAZINE DERIVATIVES AS BACE INHIBITORS FOR ALZHEIMER DISEASE TREATMENT
MA30821B1 (fr) Derives de pyrazoline utiles comme antagonistes des recepteurs de mineralocorticoïdes
GB0607954D0 (en) Organic compounds
UA94606C2 (ru) Производные тиоксантина, композиция, которая их содержит, и их применение в терапии
WO2007122634A3 (en) Pyrimidinediones as tyrosine kinase inhibitors
MX2010008460A (es) Derivado de tiazol y su uso como inhibidor de proteina-1 de adhesion vascular.
HK1146049A1 (en) Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1
AR070819A1 (es) Derivados aminometil benceno
MA31383B1 (fr) Composés pontés de cycles à six chaînons
RS51190B (sr) Aminoacilni derivati kao prolekovi i lekovi za lečenje tromboembolijskih bolesti
BR112012027387A2 (pt) composição para controle de doenças de plantas e uso da mesma
EA200701676A1 (ru) Производные дигидроимидазотиазола
ECSP099506A (es) Derivados de 2-quinolinona y 2 quinoxalinona y su utilización como agentes anti bacterianos
TW200942529A (en) Pyrrolidinyl derivatives and uses thereof
NO20060277L (no) Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger
TW200738681A (en) Isoquinoline and benzo[h]isoquinoline derivatives, their preparation and their use in therapeutics
IL161843A (en) Derivatives of 2-amino-4-pyridylmethyl-thiazoline for the preparation of medicaments for use as inhibitors of inducible no-synthase
NO20062307L (no) Spirofuropyridinarylderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application